These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21059597)

  • 1. Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy.
    Ran Y; Wu S; You Y
    J Biochem; 2011 Jan; 149(1):49-54. PubMed ID: 21059597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.
    Sun D; Zhang Z; Van do N; Huang G; Ernberg I; Hu L
    Oral Oncol; 2007 Jan; 43(1):82-7. PubMed ID: 16807071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on promoter methylation status of E-cadherin gene in nasopharyngeal carcinoma cell lines].
    Hong CQ; Ran YG; Chen JY; Wu X; You YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):532-6. PubMed ID: 21055032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
    Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
    Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells.
    Si HX; Tsao SW; Lam KY; Srivastava G; Liu Y; Wong YC; Shen ZY; Cheung AL
    Cancer Lett; 2001 Nov; 173(1):71-8. PubMed ID: 11578811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
    Chen Q; Lipkina G; Song Q; Kramer RH
    Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma].
    Li Z; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient.
    Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
    Clin Cancer Res; 2003 Mar; 9(3):1033-8. PubMed ID: 12631603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aberrant methylation of T-cadherin gene in human esophageal carcinoma cells].
    Jing Z; Zou CL; Li G; Deng X; Wu SX
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(37):2653-6. PubMed ID: 22321935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells.
    Tsao SW; Liu Y; Wang X; Yuen PW; Leung SY; Yuen ST; Pan J; Nicholls JM; Cheung AL; Wong YC
    Eur J Cancer; 2003 Mar; 39(4):524-31. PubMed ID: 12751385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
    Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene promoter hypermethylation in mouse lung tumors.
    Vuillemenot BR; Hutt JA; Belinsky SA
    Mol Cancer Res; 2006 Apr; 4(4):267-73. PubMed ID: 16603640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells].
    Li Z; Lin SX; Liang YJ
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):238-42. PubMed ID: 12839684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.